Dr. Chung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6201 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-633-5555Fax+1 469-291-2736
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2009
- Washington University in St. Louis School of MedicineClass of 2006
- Cornell UniversityB.A., Biology, Concentration in Biochemistry, 2001
Certifications & Licensure
- TX State Medical License 2018 - 2026
- NY State Medical License 2009 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Tito Bastianello Young Investigator Award MDS Foundation, 2017
- Paul Sherlock Housestaff Teaching Award, Department of Medicine MSKCC, 2017
- Early Career Award in Myelodysplastic Syndrome Research Dresner Foundation, 2017
- Join now to see all
Publications & Presentations
PubMed
- Identifying patients at risk for hereditary myeloid malignancy syndromes incorporating a novel, self-administered questionnaire to an initial screening platform.Mohammad Faizan Zahid, Kelsey Moriarty, Courtney Dryden, Olga Weinberg, Misha Asif
European Journal of Haematology. 2023-12-01 - 16 citationsNeutrophil metabolomics in severe COVID-19 reveal GAPDH as a suppressor of neutrophil extracellular trap formation.Yafeng Li, Jessica S Hook, Qing Ding, Xue Xiao, Stephen S Chung
Nature Communications. 2023-05-05 - SARS-CoV-2 Vaccination IgG Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Single Center Observation.Fieke W Hoff, Suleyman Y Goksu, Naveen Premnath, Prapti A Patel, Ruth Ikpefan
Acta Medica Academica. 2023-04-01
Journal Articles
- CD99 is a Therapeutic Target on Disease Stem Cells in Myeloid MalignanciesChung SS, Eng WS, Hu W, Khalaj M, Garrett-Bakelman FE, Tavakkoli M, Levine RL, Carroll M, Klimek VM, Melnick AM, Park CY, Sci Transl Med, 1/1/2017
- MicroRNA Dysregulation in the Myelodysplastic SyndromesChung SS, Park CY, MicroRNA, 1/1/2013
- A 75- year-old woman with thoracic spinal cord compression and chloroma (granulocytic sarcoma)Baikaidi M, Chung SS, Tallman MS, Damon LE, Walker AR, Marcucci G, Sholi AM, Morris GJ, Semin Oncol, 1/1/2012
- Join now to see all
Books/Book Chapters
Lectures
- An Analysis of the Transcriptional Response of Myelodysplastic Syndrome Stem Cells to Therapy at Single Cell Resolution.1/1/2017
- An Analysis of the Transcriptional Response of Myelodysplastic Syndrome Stem Cells to Therapy at Single Cell Resolution. Session 636. Myelodysplastic Syndromes- Basic...1/1/2016
- CD99 is a Therapeutic Target on Disease Stem Cells in the Myelodysplastic Syndromes and Acute Myeloid Leukemia. Session 6: The Myelodysplastic Syndromes.1/1/2014
- Join now to see all
Press Mentions
- Breakthrough Research Studies Are Unveiled at the MDS Foundation 14th International Symposium on Myelodysplastic SyndromesMay 8th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: